Axcelis announces $100 million increase to share repurchase authorization

Beverly, mass. , march 12, 2025 /prnewswire/ -- axcelis technologies, inc. (nasdaq: acls) a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that its board of directors has approved an additional $100 million in share repurchase authorization.
ACLS Ratings Summary
ACLS Quant Ranking